Emerging drugs for postoperative ileus

Area of Science:

• Gastroenterology
• Pharmacology
• Surgical Complications

Background:

• Postoperative ileus (POI) is a common complication following abdominal surgery, characterized by impaired gastrointestinal (GI) motility.
• It leads to delayed gastric emptying, intestinal transit, abdominal bloating, vomiting, and prolonged hospitalization.
• Opioid analgesics, commonly used for postoperative pain management, exacerbate POI by inhibiting bowel motility.

Purpose of the Study:

• To review emerging therapeutic strategies for preventing or reducing the incidence of postoperative ileus.
• To highlight advancements in pharmacological interventions for managing POI.
• To address the unmet need for effective POI treatments.

Main Methods:

• This review synthesizes current research on the pathophysiology of POI.
• It examines proposed mechanisms including neuronal responses and intestinal inflammation.
• Emerging pharmacological targets and therapeutic agents are discussed.

Main Results:

• Existing treatments for POI offer limited relief to many patients.
• Understanding the complex mechanisms of POI is crucial for developing new therapies.
• Several novel therapeutic approaches are under investigation.

Conclusions:

• New pharmacological strategies are urgently needed to prevent or reduce POI.
• Advancements in understanding POI pathophysiology offer promising therapeutic avenues.
• Emerging therapeutics have the potential to significantly improve patient care and reduce healthcare costs.